Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting.

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
ICU HospitalizationSurgical Intervention
Interventions
DEVICE

Corsano CardioWatch 287-2

Temperature readings from wearable Cardiowatch BT sensor, wearable Radius-T BT sensor, tympanic temperature and rectal temperature will be collected. Each participant will remain in the study as long as the rectal temperature is measured with a maximum of 24 hours. Other than the wearable Cardiowatch, the Radius-T sensors, and the rectal thermometer no additional interventions will take place due to the study. Temperature monitoring of patients will be performed according to hospitals routine care and will not be affected by the study. Patients may receive additional treatment to ensure best care.

Trial Locations (1)

2625AD

Reinier de Graaf Gasthuis, Delft

Sponsors
All Listed Sponsors
lead

Corsano Health B.V.

INDUSTRY

NCT06942338 - Comparative Evaluation of Body Temperature Measurement Using the CardioWatch 287-2 in an Intensive Care Setting. | Biotech Hunter | Biotech Hunter